📇 Rhumatologue · HEROUVILLE ST CLAIR · (14) · Salarié
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
7 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
150.8 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
3
3 articles ont été cités au moins 3fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
53
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
16
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
2
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Université de Nîmes
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
L’attribution de la NBI dépend de l’exercice effectif des fonctions à titre principal (CAA Lyon, 3ème chambre – N° 20LY00634 – commune d'Annemasse – 19 avril 2022 – C+ Pourvoi en cassation n° 465051 )
2022ArticleRevue ALYODA : Revue de jurisprudence de la Cour administrative d'appel de Lyon et des tribunaux administratifs de son ressort
Commentaire de l’arrêt n° 20DA02055 du 3 février 2022 de la cour administrative d’appel de Douai
2022ArticleLa lettre de la cour administrative d'appel de Douai et des tribunaux administratifs d'Amiens, Lille et Rouen
Commentaire du jugement nº 1903237 du 22 décembre 2021 du tribunal administratif d’Amiens
2022ArticleLa lettre de la cour administrative d'appel de Douai et des tribunaux administratifs d'Amiens, Lille et Rouen
Commentaire du jugement nº 1902414 du 31 mars 2021 du tribunal administratif de Lille
2022ArticleLa lettre de la cour administrative d'appel de Douai et des tribunaux administratifs d'Amiens, Lille et Rouen
La communication du dossier médical d'un patient décédé
2018ArticleRevue générale de droit médical
Le harcèlement au sein des forces armées
2017CongrèsColloque annuel de l'Association française de droit de la sécurité et de la défense
Hot ductility and flow stress of AISI 4130 and 52100-type steels
2017ArticleMaterials Science and Engineering: A
Virtual lab based on co-simulation to include impairments of wireless telecommunication such as GSM-R in the evaluation of ERTMS
2014CongrèsTRA - Transport Research Arena
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
FONDATION LA MISERICORDE - BETHARRAM
881 BD DE LA PAIX, 14200 HEROUVILLE ST CLAIR
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
ACR open rheumatology · 2021
ObjectiveThe objective of this study was to compare the efficacy and safety of two rituximab (RTX) regimens for the induction of remission in severe antineutrophil cytoplasm antibody–associated vasculitis (AAV): the four‐dose (375 mg/m2 intravenously weekly) versus the two‐dose (1000 mg intravenously biweekly) regimen.MethodsA systematic review was performed to identify studies using the four‐ and/or two‐dose RTX regimens for induction of remission in severe AAV. Disease status 6 months after RTX infusion was required for inclusion. Patients were excluded if they received concomitant cyclophosphamide or plasma exchange. The primary end point was the proportion of patients in complete remission at 6 months. The pooled estimate was obtained by using meta‐analysis methods for proportions with random effects. Secondary end points included antineutrophil cytoplasm antibody status, number of patients with B‐cell depletion, mean prednisone dose, infections, and death.ResultsA total of 27 studies and 506 patients were included for analysis: 361 patients received the four‐dose regimen, and 145 patients received the two‐dose regimen. Most patients had relapsing disease at inclusion (83% and 92% of patients, respectively). There was no significant difference between the four‐ and two‐dose regimens, with a complete remission achieved in 85% (95% confidence interval [CI]: 70‐96) and 91% (95% CI: 79‐99) of patients, respectively. At 6 months, both regimens were associated with a similar mean daily prednisone dose (8.1 mg), infections (12% in both), and death (1% vs 0%, respectively).ConclusionNo difference was found in terms of efficacy or safety between the four‐ and two‐dose RTX regimens for induction of remission in severe AAV.
Clinical rheumatology · 2024
Abstract Introduction/objectives To assess and compare the performance of the giant cell arteritis probability score (GCAPS), Ing score, Bhavsar-Khalidi score (BK score), color Doppler ultrasound (CDUS) halo count, and halo score, to predict a final diagnosis of giant cell arteritis (GCA). Method A prospective cohort study was conducted from April to December 2021. Patients with suspected new-onset GCA referred to our quaternary CDUS clinic were included. Data required to calculate each clinical and CDUS probability score was systematically collected at the initial visit. Final diagnosis of GCA was confirmed clinically 6 months after the initial visit, by two blinded vasculitis specialists. Diagnostic accuracy and receiver operator characteristic (ROC) curves for each clinical and CDUS prediction scores were assessed. Results Two hundred patients with suspected new-onset GCA were included: 58 with confirmed GCA and 142 without GCA. All patients with GCA satisfied the 2022 ACR/EULAR classification criteria. A total of 5/15 patients with GCA had a positive temporal artery biopsy. For clinical probability scores, the GCAPS showed the best sensitivity (Se, 0.983), whereas the BK score showed the best specificity (Sp, 0.711). As for CDUS, a halo count of 1 or more was found to have a Se of 0.966 and a Sp of 0.979. Combining concordant results of clinical and CDUS prediction scores showed excellent performance in predicting a final diagnosis of GCA. Conclusion Using a combination of clinical score and CDUS halo count provided an accurate GCA prediction method which should be used in the setting of GCA Fast-Track clinics. Key Points• In this prospective cohort of participants with suspected GCA, 3 clinical prediction tools and 2 ultrasound scores were compared head-to-head to predict a final diagnosis of GCA.• For clinical prediction tools, the giant cell arteritis probability score (GCAPS) had the highest sensitivity, whereas the Bhavsar-Khalidi score (BK score) had the highest specificity.• Ultrasound halo count was both sensitive and specific in predicting GCA.• Combination of a clinical prediction tool such as the GCAPS, with ultrasound halo count, provides an accurate method to predict GCA.
Rheumatology advances in practice · 2021
Abstract Objectives The aim was to compare the accuracy of colour Doppler ultrasonography (CDUS) and temporal artery biopsy (TAB) to establish the final diagnosis of GCA and to determine how the GCA probability score (GCAPS) performs as a risk stratification tool. Methods Descriptive statistics were performed on a retrospective cohort of patients referred to our vasculitis referral centre between 1 July 2017 and 1 October 2020 for suspected GCA. CDUS, TAB, centre-specific TAB (vasculitis centre vs referring hospitals) and GCAPS were compared against the final diagnosis of GCA as determined by a GCA expert; CDUS was also compared with TAB results. Results Data from 198 patients were included: 60 patients with GCA and 138 patients without GCA. Sixty-two patients had a TAB. Using the final diagnosis by a GCA expert as a reference, the sensitivity, specificity, positive predictive value and negative predictive value were 93.3%, 98.5%, 96.6% and 97.1% for CDUS and 69.2%, 100%, 100% and 81.8% for TAB, respectively. The false-negative rate was 6.7% for CDUS and 30.8% for TAB. False-negative TAB mostly occurred when performed in referring hospitals (57.1%) as opposed to our vasculitis centre (21.1%). With a cut-off at 9.5 points, sensitivity for GCAPS was 98.3% and specificity 74.3%. Conclusion CDUS of the temporal and axillary arteries showed a high sensitivity and specificity and helped to diagnose GCA in patients with negative TAB. We validated that GCAPS is a useful clinical tool, with a score of <9.5 making the diagnosis of GCA improbable.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Prostate cancer and prostatic diseases · 2026 · Journal Article
Uleri A, Baboudjian M, Leni R, Oderda M, et al.
European urology oncology · 2025 · Journal Article
Baboudjian M, Leni R, Oderda M, Peyrottes A, et al.
Revue medicale suisse · 2024 · English Abstract
Vincent B, Valerio M, Sebe P, Benamran D, et al.
Clinical rheumatology · 2024 · Journal Article
Sargi C, Ducharme-Benard S, Benard V, Meunier RS, et al.
Rheumatology advances in practice · 2021 · Journal Article
Zarka F, Rhéaume M, Belhocine M, Goulet M, et al.
L'Encephale · 2019 · Journal Article
Demesmaeker A, Benard V, Leroy A, Vaiva G
ACR open rheumatology · 2021 · Journal Article
Bénard V, Farhat C, Zarandi-Nowroozi M, Durand M, et al.
<b>Scoping Review Protocol:</b> The Intraoperative Use of Artificial intelligence in Radical Prostatectomy
Cancelled review due to lack of new evidence
<b>Scoping Review Protocol:</b> The Intraoperative Use of Artificial intelligence in Radical Prostatectomy
Cancelled review due to lack of new evidence
<b>Scoping Review Protocol:</b> The Intraoperative Use of Artificial intelligence in Radical Prostatectomy
This protocol outlines the methodology for a scoping review about the intraoperative use of artificial intelligence in radical prostatectomy. The review will adhere to the PRISMA-ScR guidelines and JBI recommendations.
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).